Here are relevant reports on : rare-disease-treatment-market
-
Conjugate Vaccines Market by Disease (Pneumococcal, DTP, Meningococcal Disease), Type (Monovalent, Multivalent), End User (Adult, Pediatric) - Forecast to 2030
The global conjugate vaccines market, valued at US$15.86 billion in 2024, stood at US$15.25 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.77 billion by the end of the period. The conjugate vaccines market is growing rapidly, driven by the rising prevalence of bacterial infections like pneumococcal, meningococcal, and Hemophilus influenzae type b (Hib), rising government immunization programs and policies, innovations in vaccine technology such as multivalent formulations, increased regulatory approvals for new products, and growing investments in research, development, and international collaborations.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis (CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals): Forecast to 2031
The Europe peritoneal dialysis market, valued at USD 2.12 billion in 2025, stood at USD 2.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.3% from 2026 to 2031, culminating in a forecasted valuation of USD 2.72 billion by the end of the period. The market is driven by several factors, such as increasing prevalence of chronic kidney-related diseases, strong demand for home-based dialysis, favorable reimbursement policies, and advancements in automated peritoneal dialysis (PD) systems and remote monitoring technologies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Peritoneal Dialysis Market by Offering (Peritoneal Dialysis Solution Bags, Machines), Modality (Continuous Ambulatory Peritoneal Dialysis Center(CAPD)), Disease Indication (End-Stage Renal Disease), End User (Hospitals) - Global Forecast to 2029
The global peritoneal dialysis market, valued at US$9.12 billion in 2023, stood at US$9.58 billion in 2024 and is projected to advance at a resilient CAGR of 5.8% from 2024 to 2029, culminating in a forecasted valuation of US$12.70 billion by the end of the period. Market growth in the Asia Pacific is attributed to the rising prevalence of acute kidney diseases, improving healthcare expenditure, and the growing accessibility of dialysis for ESRD treatment.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Bioresorbable Vascular Scaffold Market by Type (Metal, Polymer), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals) and Geography – Global Forecast to 2027
The global bioresorbable vascular scaffold market size is projected to reach ~USD 75 million by 2027 from ~USD 50 million in 2022, at a CAGR of 8.5% during the forecast period. The market is driven by factors such as rapidly increasing geriatric population and the risk of coronary artery diseases and peripheral artery diseases. On the other hand, product failures and withdrawals are expected to limit market growth to a certain extent in the coming years.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
PFAS Filtration Market by Technology (Water Treatment Systems, Water Treatment Chemicals), Place of Treatment (In-Situ, Ex-Situ), Remediation Technology, Environmental Medium, Contaminant Type, and Region - Global Forecast to 2030
The PFAS filtration market is expected to grow from USD 2.13 billion in 2025 to USD 2.99 billion by 2030, at a CAGR of 7.0% during the forecast period. The PFAS filtration market comprises several key players, including Veolia (France), AECOM (US), WSP (Canada), Clean Earth (US), Wood (UK), Xylem (US), Jacobs (US), TRC Companies, Inc. (US), Battelle Memorial Institute (US), Cyclopure, Inc. (US), Calgon Carbon Corporation (US), Regenesis (US), Mineral Technologies, Inc. (US), CDM Smith, Inc. (US), and Pentair (UK).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Biostimulants Market by Active Ingredients (Humic Substances, Seaweed Extracts, Amino Acids, Minerals & Vitamins), Crop Type, Mode of Application (Foliar treatment, Soil treatment, Seed treatment), Form, and Region - Global Forecast to 2030
The biostimulants market is projected to reach USD 7.84 billion by 2030, at a CAGR of 11.9% during the forecast period. The report profiles key players such as UPL (India), FMC Corporation (US), Corteva (US), Syngenta Group (Switzerland), Sumitomo Chemical Co., Ltd. (Japan), Nufarm (Australia), Novonesis Group (Denmark), Basf SE (Germany), Bayer AG (Germany), PI Industries (India), T.Stanes and Company Limited (India), Gowan Company (US), J.M. Huber Corporation (US), Haifa Negev technologies LTD (Israel), and Koppert (Netherlands).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Water and Wastewater Treatment Equipment Market by Product Type (Filtration, Disinfection, Desalination, Sludge Treatment, Biological), Process (Primary, Secondary And Tertiary), End-User (Municipal, Industrial), And Region -Global Forecast to 2029
The water and wastewater treatment equipment market is expected to grow from USD 68.7 billion in 2024 to USD 87.7 billion by 2029, at a CAGR of 5.0% during the forecast period. The key players in this market are Veolia (France), Xylem (US), Ecolab (US), DuPont (US), Pentair (UK), 3M (US), Aquatech International (US), Thermax Limited (India), Culligan Water (US), Calgon Carbon Corporation (US) etc.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Medical Waste Management Market by Service (Collection, Treatment, Disposal, Incineration, Recycling), Type of Waste (Non-hazardous, Infectious, Pharmaceutical), Treatment Site (Offsite, Onsite), Waste Generator (Hospital, Labs) & Region - Global Forecast to 2028
The global medical waste management market, valued at US$8.9 billion in 2022, stood at US$9.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.9% from 2023 to 2028, culminating in a forecasted valuation of US$12.2 billion by the end of the period. The increase in investments by research centers, increased number of hospitals, research laboratiories, diagnostic laboratories generating a huge amount of medical waste, improving focus on reducing the medical waste and proper management of medical waste has expected to increase the medical waste management market.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Biofungicides Market by Type (Microbial species, Botanical), Mode of Application (Soil treatment, Foliar application, Seed treatment), Species (Bacillus, Trichoderma, Streptomyces, Pseudomonas), Crop Type, Formulation, and Region – Global Forecast to 2025
The biofungicides market is expected to grow from USD 1.6 billion in 2020 to USD 3.4 billion by 2025 at a compound annual growth rate (CAGR) of 16.1% during the forecast period.Key players in the biofungicides market include BASF SE (Germany), Bayer AG (Germany), Syngenta AG (Switzerland), FMC Corporation (US), Nufarm (Australia), Novozymes (Denmark), Marrone Bio Innovations (US), Koppert Biological Systems (Netherlands), Isagro S.P.A (Italy), T. Stanes & Company Limited (India), BioWorks (US), The Stockton Group (Israel), Valent Biosciences (US), Agri Life (India). Certis U.S.A (US), Andermatt Biocontrol AG (Switzerland), Lesaffre (France), Rizobacter (Argentina), Vegalab S.A (US), Biobest Group NV (Belgium), and Biolchim (Italy).
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Crop Protection Chemicals Market by Type (Herbicides, Insecticides, Fungicides & Bactericides), Origin (Synthetic & Biopesticides), Form, Mode of Application (Foliar, Seed Treatment, Soil Treatment), Crop Type and Region - Global Forecast to 2029
According to MarketsandMarkets, the crop protection chemicals market is projected to reach USD 101.0 billion by 2029, at a CAGR of 5.0% during the forecast period. Key players in the crop protection chemicals market BASF SE (Germany), Bayer AG (Germany), FMC Corporation (US), Syngenta Group (Switzerland), Corteva (US), UPL (India), Nufarm (Australia), Sumitomo Chemical Co., Ltd (Japan), Albaugh LLC (US), Koppert (Netherlands), Gowan Company (US), American Vanguard Corporation (US), Kumiai Chemical Industry Co., Ltd (Japan), PI Industries (India), and Chr. Hansen A/S (Denmark).
- Published: June 2024
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
